Trials Interrupted
COVID-19 slowed or stopped enrollment in some cancer clinical trials.
COVID-19 slowed or stopped enrollment in some cancer clinical trials.
Advocates bring the patient perspective to the AACR Annual Meeting 2024 and leave with tools to better communicate advances to others.
We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we will…
Blood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.
A documentary film where the title says it all, except… They are housemates and were diagnosed in the same month.
A new guideline clarifies when women diagnosed with breast cancer should be offered genetic testing for inherited cancer risk.
As with last fall’s group meeting, you can install our meeting app on your smart phone (Android or Apple), or you can simply use the online version in…
Invasive cancers typically evade immune surveillance through profound local and systemic immunosuppression, preventing their elimination or control. Targeting immune interventions to prevent or intercept premalignant…
Pilot studies can answer questions about whether a given trial design is feasible within the bounds of the National Clinical Trials Network and/or the NCI…
In recent years, community sites – specifically within the NCI Community Oncology Research Program (NCORP) – have accounted for about one-half of all SWOG-credited trial…